Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05873608

Communication Issues in Patient and Provider Discussions of Immunotherapy

Communication Issues in Patient/Provider Discussions of Immunotherapy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
125 (estimated)
Sponsor
Emory University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.

Detailed description

PRIMARY OBJECTIVES: I. To identify misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources and assess if these misestimations persist post-provider conversation about immunotherapy. II. To qualitatively describe patient reported misunderstandings and to assess patient understanding of technical terms and metaphors used in the immunotherapy conversation. III. To identify provider and patient preferences for information to be communicated about immunotherapy. IV. Develop videos that describe immunotherapy and test their efficacy in improving understanding using pre and post methodology. OUTLINE: Patients and their providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes. Understanding of educational videos is then tested.

Conditions

Interventions

TypeNameDescription
OTHEREducational videoTesting an educational video
OTHERInterviewParticipate in interview
OTHERObservationUndergo observation

Timeline

Start date
2016-10-06
Primary completion
2027-09-17
Completion
2027-11-17
First posted
2023-05-24
Last updated
2026-04-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05873608. Inclusion in this directory is not an endorsement.